Find your next paid study

FBD Biologics LimitedNCT05892718

~$150 – $4,200

Actual pay is set by the research site.

Triple Negative Breast CancerBreast CancerEndometrial Cancer+4 more

A Phase 1/2, First-in-human, Multicenter Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

A Study of Emi-Le in Participants with Solid Tumors

Day One Biopharmaceuticals, Inc.NCT05377996

~$150 – $4,200

Actual pay is set by the research site.

Medication AdherenceHeart Failure

Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies in Patients With Heart Failure

People with heart failure who do not take their medications as prescribed are at high risk of complications leading to hospitalization, death and poor quality …

~$10 – $1,125

Actual pay is set by the research site.

Jia-Rong WuNCT05548413

Urothelial CancerMetastatic Urothelial CarcinomaMetastatic Urothelial Carcinoma of the Renal Pelvis and Ureter+1 more

Combinations of Sacituzumab Govitecan Plus Enfortumab Vedotin and Pembrolizumab for Metastatic Urothelial Carcinoma: the Double Antibody Drug Conjugate (DAD) and Double Antibody Drug Conjugate With Immunotherapy (DAD-IO) Phase I/II Trial

Phase I of this research study will assess what doses of Sacituzumab Govitecan and Enfortumab Vedotin can be safely combined in the treatment of metastatic uro…

Dana-Farber Cancer InstituteNCT04724018

~$150 – $4,500

Actual pay is set by the research site.

Shared Decision-MakingQuality of LifeAdvanced Illness+1 more

EMBRACE - Empowering Monterey Bay Residents for Activated, Collaborative, and Equitable Care

The purpose of the EMBRACE Study is to evaluate whether a facilitated intervention improves shared decision-making (SDM) and patient activation among low-incom…

Stanford UniversityNCT07652359

~$10 – $750

Actual pay is set by the research site.

Supporting Treatment Resilience With Optimized Nutrition and Guided Exercise in Head and Neck Cancer Patients Undergoing Chemoradiation

The purpose of this study to find out whether a structured lifestyle intervention-combining nutrition counseling, guided exercise, and wellness education-can h…

Head and Neck Cancer

~$10 – $1,125

Actual pay is set by the research site.

Renown HealthNCT07160296

High Grade B-Cell Non-Hodgkin's LymphomaIntermediate Grade B-Cell Non-Hodgkin's LymphomaRecurrent B-Cell Non-Hodgkin Lymphoma+1 more

A Pilot / Feasibility Study of Autologous CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine in Patients With Intermediate or High Grade B-Lineage Non-Hodgkin Lymphoma

This phase I trial studies the safety and feasibility of cytomegalovirus (CMV) specific CD19-chimeric antigen receptor (CAR) T cells in combination with the CM…

City of Hope Medical CenterNCT05801913

~$150 – $3,000

Actual pay is set by the research site.

Lung CancerHead and Neck CancerThyroid Cancer+5 more

Improving the Timeliness and Quality of Care for Rural Cancer Patients With Solid Tumors

This study will assess if the CARES (Cancer Advocacy, Resources, Education and Support) intervention improves time to start of treatment after diagnosis and ti…

University of Colorado, DenverNCT04916990

~$10 – $750

Actual pay is set by the research site.

Phase 2

MC240701 Decentralized Pilot Study of Triple Oral Metronomic Chemotherapy for Patients With Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

This phase II trial gathers information on the feasibility, safety, and effect of giving methotrexate, erlotinib, and celecoxib in treating head and neck cance…

Metastatic Oral Cavity CarcinomaRecurrent Oral Cavity CarcinomaStage IVC Lip and Oral Cavity Cancer AJCC v8+15 more

Cancer-Associated AnorexiaHead and Neck Squamous Cell CarcinomaNeck Squamous Cell Carcinoma of Unknown Primary

~$75 – $2,000

Phase 2

Managing Anorexia During Chemoradiation With Olanzapine (MACRO)

This phase II trial compares the effect of adding olanzapine to standard of care symptom management for nausea to standard of care alone in managing an abnorma…

Roswell Park Cancer InstituteNCT06995508

~$75 – $3,000

Actual pay is set by the research site.

Locally Recurrent Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell CarcinomaRefractory Head and Neck Squamous Cell Carcinoma

Phase Ib Study of Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy (SBRT) in Patients With Locoregionally Recurrent, Refractory, or Oligometastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

This phase Ib trial tests the safety, side effects and how well losartan, pembrolizumab and stereotactic body radiation therapy (SBRT) for the treatment of pat…

University of California, DavisNCT06211335

~$150 – $3,000

Actual pay is set by the research site.

Phase 2

HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma

This study will compare outcomes for M1 iCCA patients treated with and without L-RT by reviewing iCCA patients found to have M1 disease at initial diagnosis at…

Advanced Intrahepatic Cholangiocarcinoma